nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—SIGMAR1—Tamoxifen—pancreatic cancer	0.0482	0.0688	CbGbCtD
Progesterone—ESR1—Tamoxifen—pancreatic cancer	0.039	0.0556	CbGbCtD
Progesterone—ABCB11—Tamoxifen—pancreatic cancer	0.039	0.0556	CbGbCtD
Progesterone—CYP1B1—Tamoxifen—pancreatic cancer	0.039	0.0556	CbGbCtD
Progesterone—CYP1B1—Erlotinib—pancreatic cancer	0.0331	0.0473	CbGbCtD
Progesterone—SLC22A3—Irinotecan—pancreatic cancer	0.0326	0.0465	CbGbCtD
Progesterone—CYP1B1—Docetaxel—pancreatic cancer	0.0219	0.0313	CbGbCtD
Progesterone—ABCC1—Epirubicin—pancreatic cancer	0.0219	0.0312	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—pancreatic cancer	0.0215	0.0307	CbGbCtD
Progesterone—ABCC1—Irinotecan—pancreatic cancer	0.0213	0.0303	CbGbCtD
Progesterone—CYP2A6—Tamoxifen—pancreatic cancer	0.02	0.0286	CbGbCtD
Progesterone—CYP1A1—Tamoxifen—pancreatic cancer	0.0171	0.0244	CbGbCtD
Progesterone—ABCB11—Doxorubicin—pancreatic cancer	0.0163	0.0233	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—pancreatic cancer	0.0163	0.0233	CbGbCtD
Progesterone—ABCC1—Docetaxel—pancreatic cancer	0.0156	0.0222	CbGbCtD
Progesterone—CYP2A6—Fluorouracil—pancreatic cancer	0.0147	0.021	CbGbCtD
Progesterone—CYP1A1—Erlotinib—pancreatic cancer	0.0145	0.0207	CbGbCtD
Progesterone—CYP3A7—Tamoxifen—pancreatic cancer	0.0137	0.0195	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0137	0.0195	CbGbCtD
Progesterone—ABCC1—Doxorubicin—pancreatic cancer	0.0116	0.0166	CbGbCtD
Progesterone—SLC10A1—bile duct—pancreatic cancer	0.0114	0.223	CbGeAlD
Progesterone—ABCB11—bile duct—pancreatic cancer	0.0113	0.22	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0105	0.015	CbGbCtD
Progesterone—CYP3A7—Irinotecan—pancreatic cancer	0.0105	0.015	CbGbCtD
Progesterone—CYP3A5—Tamoxifen—pancreatic cancer	0.0103	0.0146	CbGbCtD
Progesterone—CYP2C8—Tamoxifen—pancreatic cancer	0.00987	0.0141	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—pancreatic cancer	0.0096	0.0137	CbGbCtD
Progesterone—SLC10A1—bile—pancreatic cancer	0.00876	0.171	CbGeAlD
Progesterone—CYP3A5—Erlotinib—pancreatic cancer	0.00873	0.0125	CbGbCtD
Progesterone—ABCB11—bile—pancreatic cancer	0.00866	0.169	CbGeAlD
Progesterone—CYP2C8—Erlotinib—pancreatic cancer	0.00839	0.012	CbGbCtD
Progesterone—CYP2C19—Tamoxifen—pancreatic cancer	0.00828	0.0118	CbGbCtD
Progesterone—CYP3A5—Irinotecan—pancreatic cancer	0.00788	0.0112	CbGbCtD
Progesterone—CYP3A7—Docetaxel—pancreatic cancer	0.0077	0.011	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0077	0.011	CbGbCtD
Progesterone—CYP3A7—Sunitinib—pancreatic cancer	0.00766	0.0109	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00766	0.0109	CbGbCtD
Progesterone—CYP1A2—Tamoxifen—pancreatic cancer	0.00764	0.0109	CbGbCtD
Progesterone—CYP2C8—Fluorouracil—pancreatic cancer	0.00727	0.0104	CbGbCtD
Progesterone—CYP2C9—Tamoxifen—pancreatic cancer	0.00688	0.00982	CbGbCtD
Progesterone—ABCB1—Tamoxifen—pancreatic cancer	0.00668	0.00953	CbGbCtD
Progesterone—CYP1A2—Erlotinib—pancreatic cancer	0.0065	0.00927	CbGbCtD
Progesterone—CYP2D6—Tamoxifen—pancreatic cancer	0.00629	0.00898	CbGbCtD
Progesterone—CYP3A5—Docetaxel—pancreatic cancer	0.00578	0.00824	CbGbCtD
Progesterone—ABCB1—Gemcitabine—pancreatic cancer	0.00576	0.00821	CbGbCtD
Progesterone—CYP3A5—Sunitinib—pancreatic cancer	0.00575	0.0082	CbGbCtD
Progesterone—ABCB1—Erlotinib—pancreatic cancer	0.00568	0.00811	CbGbCtD
Progesterone—CYP1A2—Fluorouracil—pancreatic cancer	0.00563	0.00803	CbGbCtD
Progesterone—CYP2D6—Erlotinib—pancreatic cancer	0.00535	0.00764	CbGbCtD
Progesterone—ABCB1—Irinotecan—pancreatic cancer	0.00513	0.00732	CbGbCtD
Progesterone—CYP2C9—Fluorouracil—pancreatic cancer	0.00507	0.00724	CbGbCtD
Progesterone—CYP3A4—Tamoxifen—pancreatic cancer	0.004	0.00571	CbGbCtD
Progesterone—ABCB1—Docetaxel—pancreatic cancer	0.00376	0.00536	CbGbCtD
Progesterone—ABCB1—Sunitinib—pancreatic cancer	0.00374	0.00534	CbGbCtD
Progesterone—CYP3A4—Erlotinib—pancreatic cancer	0.0034	0.00486	CbGbCtD
Progesterone—CYP3A4—Irinotecan—pancreatic cancer	0.00307	0.00439	CbGbCtD
Progesterone—ABCB1—Doxorubicin—pancreatic cancer	0.0028	0.004	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—pancreatic cancer	0.00264	0.00377	CbGbCtD
Progesterone—CYP3A4—Docetaxel—pancreatic cancer	0.00225	0.00321	CbGbCtD
Progesterone—CYP3A4—Sunitinib—pancreatic cancer	0.00224	0.0032	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—pancreatic cancer	0.00168	0.0024	CbGbCtD
Progesterone—SLC10A1—digestive system—pancreatic cancer	0.000957	0.0187	CbGeAlD
Progesterone—ABCB11—digestive system—pancreatic cancer	0.000946	0.0185	CbGeAlD
Progesterone—SIGMAR1—islet of Langerhans—pancreatic cancer	0.000825	0.0161	CbGeAlD
Progesterone—SLC22A2—digestive system—pancreatic cancer	0.000759	0.0148	CbGeAlD
Progesterone—NR3C2—digestive system—pancreatic cancer	0.000602	0.0118	CbGeAlD
Progesterone—SIGMAR1—pancreas—pancreatic cancer	0.00058	0.0113	CbGeAlD
Progesterone—CYP3A5—islet of Langerhans—pancreatic cancer	0.000542	0.0106	CbGeAlD
Progesterone—NR3C1—islet of Langerhans—pancreatic cancer	0.000538	0.0105	CbGeAlD
Progesterone—CYP1B1—digestive system—pancreatic cancer	0.000471	0.00921	CbGeAlD
Progesterone—AR—digestive system—pancreatic cancer	0.000446	0.00872	CbGeAlD
Progesterone—ESR1—digestive system—pancreatic cancer	0.000438	0.00856	CbGeAlD
Progesterone—CYP2C19—digestive system—pancreatic cancer	0.000413	0.00808	CbGeAlD
Progesterone—CYP3A5—pancreas—pancreatic cancer	0.000381	0.00745	CbGeAlD
Progesterone—NR3C1—pancreas—pancreatic cancer	0.000378	0.0074	CbGeAlD
Progesterone—CYP1A2—digestive system—pancreatic cancer	0.000338	0.0066	CbGeAlD
Progesterone—CYP1A1—digestive system—pancreatic cancer	0.000333	0.00651	CbGeAlD
Progesterone—CYP3A5—digestive system—pancreatic cancer	0.000326	0.00637	CbGeAlD
Progesterone—NR3C1—digestive system—pancreatic cancer	0.000323	0.00632	CbGeAlD
Progesterone—CYP2C9—digestive system—pancreatic cancer	0.00032	0.00626	CbGeAlD
Progesterone—ABCB1—islet of Langerhans—pancreatic cancer	0.000288	0.00563	CbGeAlD
Progesterone—CYP3A4—digestive system—pancreatic cancer	0.000244	0.00478	CbGeAlD
Progesterone—CYP2D6—digestive system—pancreatic cancer	0.00024	0.0047	CbGeAlD
Progesterone—ABCB1—pancreas—pancreatic cancer	0.000203	0.00396	CbGeAlD
Progesterone—ABCB1—digestive system—pancreatic cancer	0.000173	0.00338	CbGeAlD
Progesterone—Chest pain—Docetaxel—pancreatic cancer	7.66e-05	0.000429	CcSEcCtD
Progesterone—Myalgia—Docetaxel—pancreatic cancer	7.66e-05	0.000429	CcSEcCtD
Progesterone—Arthralgia—Docetaxel—pancreatic cancer	7.66e-05	0.000429	CcSEcCtD
Progesterone—Nausea—Sunitinib—pancreatic cancer	7.66e-05	0.000429	CcSEcCtD
Progesterone—Asthenia—Irinotecan—pancreatic cancer	7.62e-05	0.000427	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—pancreatic cancer	7.61e-05	0.000427	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	7.6e-05	0.000426	CcSEcCtD
Progesterone—Jaundice—Epirubicin—pancreatic cancer	7.57e-05	0.000424	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—pancreatic cancer	7.55e-05	0.000423	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—pancreatic cancer	7.55e-05	0.000423	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—pancreatic cancer	7.53e-05	0.000422	CcSEcCtD
Progesterone—Hypersensitivity—Fluorouracil—pancreatic cancer	7.49e-05	0.00042	CcSEcCtD
Progesterone—Dry mouth—Docetaxel—pancreatic cancer	7.49e-05	0.00042	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	7.49e-05	0.00042	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—pancreatic cancer	7.44e-05	0.000417	CcSEcCtD
Progesterone—Asthenia—Gemcitabine—pancreatic cancer	7.42e-05	0.000416	CcSEcCtD
Progesterone—Confusional state—Docetaxel—pancreatic cancer	7.4e-05	0.000415	CcSEcCtD
Progesterone—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.34e-05	0.000412	CcSEcCtD
Progesterone—Oedema—Docetaxel—pancreatic cancer	7.34e-05	0.000411	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—pancreatic cancer	7.34e-05	0.000411	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—pancreatic cancer	7.33e-05	0.000411	CcSEcCtD
Progesterone—Pruritus—Gemcitabine—pancreatic cancer	7.32e-05	0.00041	CcSEcCtD
Progesterone—Infection—Docetaxel—pancreatic cancer	7.29e-05	0.000409	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—pancreatic cancer	7.29e-05	0.000409	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—pancreatic cancer	7.28e-05	0.000408	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.27e-05	0.000407	CcSEcCtD
Progesterone—Diarrhoea—Irinotecan—pancreatic cancer	7.27e-05	0.000407	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—pancreatic cancer	7.22e-05	0.000405	CcSEcCtD
Progesterone—Shock—Docetaxel—pancreatic cancer	7.22e-05	0.000405	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—pancreatic cancer	7.2e-05	0.000403	CcSEcCtD
Progesterone—Pruritus—Fluorouracil—pancreatic cancer	7.2e-05	0.000403	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—pancreatic cancer	7.18e-05	0.000403	CcSEcCtD
Progesterone—Infestation—Doxorubicin—pancreatic cancer	7.18e-05	0.000403	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—pancreatic cancer	7.18e-05	0.000403	CcSEcCtD
Progesterone—Tachycardia—Docetaxel—pancreatic cancer	7.16e-05	0.000402	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—pancreatic cancer	7.13e-05	0.0004	CcSEcCtD
Progesterone—Diarrhoea—Gemcitabine—pancreatic cancer	7.08e-05	0.000397	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.04e-05	0.000395	CcSEcCtD
Progesterone—Dizziness—Irinotecan—pancreatic cancer	7.02e-05	0.000394	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—pancreatic cancer	7e-05	0.000393	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—pancreatic cancer	7e-05	0.000392	CcSEcCtD
Progesterone—Anorexia—Docetaxel—pancreatic cancer	7e-05	0.000392	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—pancreatic cancer	6.99e-05	0.000392	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—pancreatic cancer	6.98e-05	0.000391	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—pancreatic cancer	6.98e-05	0.000391	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—pancreatic cancer	6.97e-05	0.000391	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—pancreatic cancer	6.97e-05	0.000391	CcSEcCtD
Progesterone—Diarrhoea—Fluorouracil—pancreatic cancer	6.96e-05	0.00039	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—pancreatic cancer	6.92e-05	0.000388	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—pancreatic cancer	6.88e-05	0.000386	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—pancreatic cancer	6.87e-05	0.000385	CcSEcCtD
Progesterone—Hypotension—Docetaxel—pancreatic cancer	6.86e-05	0.000384	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—pancreatic cancer	6.85e-05	0.000384	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—pancreatic cancer	6.83e-05	0.000383	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	6.79e-05	0.000381	CcSEcCtD
Progesterone—Vomiting—Irinotecan—pancreatic cancer	6.75e-05	0.000378	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—pancreatic cancer	6.74e-05	0.000378	CcSEcCtD
Progesterone—Dizziness—Fluorouracil—pancreatic cancer	6.73e-05	0.000377	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—pancreatic cancer	6.72e-05	0.000376	CcSEcCtD
Progesterone—Rash—Irinotecan—pancreatic cancer	6.7e-05	0.000375	CcSEcCtD
Progesterone—Dermatitis—Irinotecan—pancreatic cancer	6.69e-05	0.000375	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.69e-05	0.000375	CcSEcCtD
Progesterone—Headache—Irinotecan—pancreatic cancer	6.65e-05	0.000373	CcSEcCtD
Progesterone—Insomnia—Docetaxel—pancreatic cancer	6.64e-05	0.000372	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—pancreatic cancer	6.59e-05	0.000369	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—pancreatic cancer	6.59e-05	0.000369	CcSEcCtD
Progesterone—Vomiting—Gemcitabine—pancreatic cancer	6.58e-05	0.000369	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—pancreatic cancer	6.54e-05	0.000367	CcSEcCtD
Progesterone—Somnolence—Docetaxel—pancreatic cancer	6.53e-05	0.000366	CcSEcCtD
Progesterone—Rash—Gemcitabine—pancreatic cancer	6.52e-05	0.000366	CcSEcCtD
Progesterone—Dermatitis—Gemcitabine—pancreatic cancer	6.52e-05	0.000365	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—pancreatic cancer	6.51e-05	0.000365	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—pancreatic cancer	6.5e-05	0.000364	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—pancreatic cancer	6.48e-05	0.000363	CcSEcCtD
Progesterone—Headache—Gemcitabine—pancreatic cancer	6.48e-05	0.000363	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—pancreatic cancer	6.47e-05	0.000363	CcSEcCtD
Progesterone—Vomiting—Fluorouracil—pancreatic cancer	6.47e-05	0.000362	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—pancreatic cancer	6.46e-05	0.000362	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—pancreatic cancer	6.46e-05	0.000362	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—pancreatic cancer	6.45e-05	0.000361	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—pancreatic cancer	6.45e-05	0.000361	CcSEcCtD
Progesterone—Rash—Fluorouracil—pancreatic cancer	6.41e-05	0.000359	CcSEcCtD
Progesterone—Dermatitis—Fluorouracil—pancreatic cancer	6.41e-05	0.000359	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—pancreatic cancer	6.4e-05	0.000359	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—pancreatic cancer	6.38e-05	0.000358	CcSEcCtD
Progesterone—Headache—Fluorouracil—pancreatic cancer	6.37e-05	0.000357	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.37e-05	0.000357	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—pancreatic cancer	6.35e-05	0.000356	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.34e-05	0.000355	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—pancreatic cancer	6.34e-05	0.000355	CcSEcCtD
Progesterone—Fatigue—Docetaxel—pancreatic cancer	6.33e-05	0.000355	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—pancreatic cancer	6.32e-05	0.000354	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—pancreatic cancer	6.32e-05	0.000354	CcSEcCtD
Progesterone—Nausea—Irinotecan—pancreatic cancer	6.31e-05	0.000354	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—pancreatic cancer	6.29e-05	0.000353	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—pancreatic cancer	6.28e-05	0.000352	CcSEcCtD
Progesterone—Pain—Docetaxel—pancreatic cancer	6.28e-05	0.000352	CcSEcCtD
Progesterone—Constipation—Docetaxel—pancreatic cancer	6.28e-05	0.000352	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—pancreatic cancer	6.21e-05	0.000348	CcSEcCtD
Progesterone—Alopecia—Epirubicin—pancreatic cancer	6.16e-05	0.000345	CcSEcCtD
Progesterone—Nausea—Gemcitabine—pancreatic cancer	6.14e-05	0.000344	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—pancreatic cancer	6.11e-05	0.000342	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—pancreatic cancer	6.1e-05	0.000342	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—pancreatic cancer	6.07e-05	0.00034	CcSEcCtD
Progesterone—Erythema—Epirubicin—pancreatic cancer	6.07e-05	0.00034	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—pancreatic cancer	6.05e-05	0.000339	CcSEcCtD
Progesterone—Nausea—Fluorouracil—pancreatic cancer	6.04e-05	0.000339	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—pancreatic cancer	6.03e-05	0.000338	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—pancreatic cancer	6.01e-05	0.000337	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—pancreatic cancer	6e-05	0.000336	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—pancreatic cancer	5.98e-05	0.000335	CcSEcCtD
Progesterone—Flatulence—Epirubicin—pancreatic cancer	5.98e-05	0.000335	CcSEcCtD
Progesterone—Tension—Epirubicin—pancreatic cancer	5.95e-05	0.000334	CcSEcCtD
Progesterone—Nervousness—Epirubicin—pancreatic cancer	5.89e-05	0.00033	CcSEcCtD
Progesterone—Back pain—Epirubicin—pancreatic cancer	5.87e-05	0.000329	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—pancreatic cancer	5.85e-05	0.000328	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—pancreatic cancer	5.83e-05	0.000327	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—pancreatic cancer	5.82e-05	0.000326	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.81e-05	0.000326	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—pancreatic cancer	5.8e-05	0.000325	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—pancreatic cancer	5.8e-05	0.000325	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—pancreatic cancer	5.72e-05	0.00032	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—pancreatic cancer	5.7e-05	0.000319	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—pancreatic cancer	5.65e-05	0.000317	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—pancreatic cancer	5.63e-05	0.000315	CcSEcCtD
Progesterone—Erythema—Doxorubicin—pancreatic cancer	5.61e-05	0.000315	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—pancreatic cancer	5.61e-05	0.000315	CcSEcCtD
Progesterone—Anaemia—Epirubicin—pancreatic cancer	5.61e-05	0.000314	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—pancreatic cancer	5.53e-05	0.00031	CcSEcCtD
Progesterone—Tension—Doxorubicin—pancreatic cancer	5.51e-05	0.000309	CcSEcCtD
Progesterone—Malaise—Epirubicin—pancreatic cancer	5.47e-05	0.000307	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—pancreatic cancer	5.45e-05	0.000306	CcSEcCtD
Progesterone—Vertigo—Epirubicin—pancreatic cancer	5.45e-05	0.000305	CcSEcCtD
Progesterone—Syncope—Epirubicin—pancreatic cancer	5.44e-05	0.000305	CcSEcCtD
Progesterone—Back pain—Doxorubicin—pancreatic cancer	5.43e-05	0.000304	CcSEcCtD
Progesterone—Hypersensitivity—Docetaxel—pancreatic cancer	5.41e-05	0.000303	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—pancreatic cancer	5.4e-05	0.000302	CcSEcCtD
Progesterone—Palpitations—Epirubicin—pancreatic cancer	5.36e-05	0.0003	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—pancreatic cancer	5.33e-05	0.000299	CcSEcCtD
Progesterone—Cough—Epirubicin—pancreatic cancer	5.29e-05	0.000297	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—pancreatic cancer	5.29e-05	0.000297	CcSEcCtD
Progesterone—Asthenia—Docetaxel—pancreatic cancer	5.27e-05	0.000295	CcSEcCtD
Progesterone—Convulsion—Epirubicin—pancreatic cancer	5.26e-05	0.000295	CcSEcCtD
Progesterone—Hypertension—Epirubicin—pancreatic cancer	5.24e-05	0.000294	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.21e-05	0.000292	CcSEcCtD
Progesterone—Pruritus—Docetaxel—pancreatic cancer	5.19e-05	0.000291	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—pancreatic cancer	5.19e-05	0.000291	CcSEcCtD
Progesterone—Chest pain—Epirubicin—pancreatic cancer	5.16e-05	0.000289	CcSEcCtD
Progesterone—Myalgia—Epirubicin—pancreatic cancer	5.16e-05	0.000289	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—pancreatic cancer	5.16e-05	0.000289	CcSEcCtD
Progesterone—Anxiety—Epirubicin—pancreatic cancer	5.15e-05	0.000288	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.13e-05	0.000287	CcSEcCtD
Progesterone—Discomfort—Epirubicin—pancreatic cancer	5.1e-05	0.000286	CcSEcCtD
Progesterone—Malaise—Doxorubicin—pancreatic cancer	5.06e-05	0.000284	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—pancreatic cancer	5.05e-05	0.000283	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—pancreatic cancer	5.04e-05	0.000283	CcSEcCtD
Progesterone—Syncope—Doxorubicin—pancreatic cancer	5.03e-05	0.000282	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—pancreatic cancer	5.02e-05	0.000282	CcSEcCtD
Progesterone—Confusional state—Epirubicin—pancreatic cancer	4.99e-05	0.00028	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—pancreatic cancer	4.96e-05	0.000278	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—pancreatic cancer	4.95e-05	0.000278	CcSEcCtD
Progesterone—Oedema—Epirubicin—pancreatic cancer	4.95e-05	0.000278	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—pancreatic cancer	4.93e-05	0.000277	CcSEcCtD
Progesterone—Infection—Epirubicin—pancreatic cancer	4.92e-05	0.000276	CcSEcCtD
Progesterone—Cough—Doxorubicin—pancreatic cancer	4.9e-05	0.000275	CcSEcCtD
Progesterone—Shock—Epirubicin—pancreatic cancer	4.87e-05	0.000273	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—pancreatic cancer	4.86e-05	0.000273	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—pancreatic cancer	4.86e-05	0.000272	CcSEcCtD
Progesterone—Dizziness—Docetaxel—pancreatic cancer	4.85e-05	0.000272	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—pancreatic cancer	4.85e-05	0.000272	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—pancreatic cancer	4.83e-05	0.000271	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—pancreatic cancer	4.81e-05	0.00027	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—pancreatic cancer	4.79e-05	0.000268	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—pancreatic cancer	4.78e-05	0.000268	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—pancreatic cancer	4.78e-05	0.000268	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—pancreatic cancer	4.78e-05	0.000268	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—pancreatic cancer	4.76e-05	0.000267	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.75e-05	0.000266	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—pancreatic cancer	4.72e-05	0.000265	CcSEcCtD
Progesterone—Anorexia—Epirubicin—pancreatic cancer	4.72e-05	0.000265	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—pancreatic cancer	4.67e-05	0.000262	CcSEcCtD
Progesterone—Vomiting—Docetaxel—pancreatic cancer	4.67e-05	0.000262	CcSEcCtD
Progesterone—Rash—Docetaxel—pancreatic cancer	4.63e-05	0.000259	CcSEcCtD
Progesterone—Hypotension—Epirubicin—pancreatic cancer	4.63e-05	0.000259	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—pancreatic cancer	4.62e-05	0.000259	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—pancreatic cancer	4.62e-05	0.000259	CcSEcCtD
Progesterone—Headache—Docetaxel—pancreatic cancer	4.6e-05	0.000258	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.58e-05	0.000257	CcSEcCtD
Progesterone—Oedema—Doxorubicin—pancreatic cancer	4.58e-05	0.000257	CcSEcCtD
Progesterone—Infection—Doxorubicin—pancreatic cancer	4.55e-05	0.000255	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.51e-05	0.000253	CcSEcCtD
Progesterone—Shock—Doxorubicin—pancreatic cancer	4.51e-05	0.000253	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—pancreatic cancer	4.49e-05	0.000252	CcSEcCtD
Progesterone—Insomnia—Epirubicin—pancreatic cancer	4.48e-05	0.000251	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—pancreatic cancer	4.47e-05	0.000251	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—pancreatic cancer	4.45e-05	0.000249	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—pancreatic cancer	4.45e-05	0.000249	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.43e-05	0.000248	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—pancreatic cancer	4.41e-05	0.000247	CcSEcCtD
Progesterone—Somnolence—Epirubicin—pancreatic cancer	4.4e-05	0.000247	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—pancreatic cancer	4.37e-05	0.000245	CcSEcCtD
Progesterone—Nausea—Docetaxel—pancreatic cancer	4.36e-05	0.000244	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—pancreatic cancer	4.36e-05	0.000244	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—pancreatic cancer	4.3e-05	0.000241	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—pancreatic cancer	4.28e-05	0.00024	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.27e-05	0.00024	CcSEcCtD
Progesterone—Fatigue—Epirubicin—pancreatic cancer	4.27e-05	0.000239	CcSEcCtD
Progesterone—Pain—Epirubicin—pancreatic cancer	4.23e-05	0.000237	CcSEcCtD
Progesterone—Constipation—Epirubicin—pancreatic cancer	4.23e-05	0.000237	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.17e-05	0.000234	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—pancreatic cancer	4.14e-05	0.000232	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—pancreatic cancer	4.11e-05	0.000231	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—pancreatic cancer	4.08e-05	0.000229	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—pancreatic cancer	4.08e-05	0.000229	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—pancreatic cancer	4.07e-05	0.000228	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.05e-05	0.000227	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—pancreatic cancer	4.03e-05	0.000226	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—pancreatic cancer	3.98e-05	0.000223	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.96e-05	0.000222	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—pancreatic cancer	3.95e-05	0.000221	CcSEcCtD
Progesterone—Urticaria—Epirubicin—pancreatic cancer	3.93e-05	0.00022	CcSEcCtD
Progesterone—Constipation—Doxorubicin—pancreatic cancer	3.92e-05	0.00022	CcSEcCtD
Progesterone—Pain—Doxorubicin—pancreatic cancer	3.92e-05	0.00022	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—pancreatic cancer	3.91e-05	0.000219	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—pancreatic cancer	3.91e-05	0.000219	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—pancreatic cancer	3.78e-05	0.000212	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.75e-05	0.00021	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—pancreatic cancer	3.65e-05	0.000204	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—pancreatic cancer	3.64e-05	0.000204	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—pancreatic cancer	3.62e-05	0.000203	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—pancreatic cancer	3.62e-05	0.000203	CcSEcCtD
Progesterone—Asthenia—Epirubicin—pancreatic cancer	3.55e-05	0.000199	CcSEcCtD
Progesterone—Pruritus—Epirubicin—pancreatic cancer	3.5e-05	0.000196	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—pancreatic cancer	3.39e-05	0.00019	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—pancreatic cancer	3.38e-05	0.000189	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—pancreatic cancer	3.29e-05	0.000184	CcSEcCtD
Progesterone—Dizziness—Epirubicin—pancreatic cancer	3.27e-05	0.000184	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—pancreatic cancer	3.24e-05	0.000182	CcSEcCtD
Progesterone—Vomiting—Epirubicin—pancreatic cancer	3.15e-05	0.000176	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—pancreatic cancer	3.13e-05	0.000176	CcSEcCtD
Progesterone—Rash—Epirubicin—pancreatic cancer	3.12e-05	0.000175	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—pancreatic cancer	3.12e-05	0.000175	CcSEcCtD
Progesterone—Headache—Epirubicin—pancreatic cancer	3.1e-05	0.000174	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—pancreatic cancer	3.03e-05	0.00017	CcSEcCtD
Progesterone—Nausea—Epirubicin—pancreatic cancer	2.94e-05	0.000165	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—pancreatic cancer	2.91e-05	0.000163	CcSEcCtD
Progesterone—Rash—Doxorubicin—pancreatic cancer	2.89e-05	0.000162	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—pancreatic cancer	2.89e-05	0.000162	CcSEcCtD
Progesterone—Headache—Doxorubicin—pancreatic cancer	2.87e-05	0.000161	CcSEcCtD
Progesterone—Nausea—Doxorubicin—pancreatic cancer	2.72e-05	0.000153	CcSEcCtD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.6e-06	8.04e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CD44—pancreatic cancer	5.58e-06	8.01e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APOE—pancreatic cancer	5.56e-06	7.99e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.55e-06	7.97e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—pancreatic cancer	5.52e-06	7.92e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.5e-06	7.89e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GCG—pancreatic cancer	5.48e-06	7.87e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KDR—pancreatic cancer	5.45e-06	7.82e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.42e-06	7.78e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	5.42e-06	7.78e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TYMS—pancreatic cancer	5.42e-06	7.78e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—pancreatic cancer	5.42e-06	7.78e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GCG—pancreatic cancer	5.35e-06	7.68e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	5.34e-06	7.66e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.3e-06	7.61e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—pancreatic cancer	5.28e-06	7.58e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CD44—pancreatic cancer	5.26e-06	7.55e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SRC—pancreatic cancer	5.25e-06	7.54e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PPARG—pancreatic cancer	5.23e-06	7.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CD44—pancreatic cancer	5.22e-06	7.49e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	5.18e-06	7.44e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—pancreatic cancer	5.17e-06	7.42e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—STK11—pancreatic cancer	5.16e-06	7.4e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—pancreatic cancer	5.15e-06	7.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	5.13e-06	7.37e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	5.13e-06	7.37e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	5.12e-06	7.35e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CB—pancreatic cancer	5.12e-06	7.35e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	5.12e-06	7.34e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	5.11e-06	7.34e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.11e-06	7.33e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—pancreatic cancer	5.07e-06	7.28e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—pancreatic cancer	5.07e-06	7.27e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.06e-06	7.26e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—pancreatic cancer	5.05e-06	7.25e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GCG—pancreatic cancer	5.04e-06	7.24e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—STK11—pancreatic cancer	5.03e-06	7.22e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	5.02e-06	7.21e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—pancreatic cancer	5.02e-06	7.21e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.01e-06	7.19e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GCG—pancreatic cancer	5e-06	7.18e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.97e-06	7.13e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGF—pancreatic cancer	4.96e-06	7.12e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	4.95e-06	7.1e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	4.93e-06	7.08e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—pancreatic cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—SRC—pancreatic cancer	4.9e-06	7.03e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.84e-06	6.95e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	4.77e-06	6.84e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	4.77e-06	6.84e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.76e-06	6.83e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—STK11—pancreatic cancer	4.74e-06	6.81e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	4.72e-06	6.78e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—pancreatic cancer	4.72e-06	6.78e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—pancreatic cancer	4.71e-06	6.76e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—pancreatic cancer	4.71e-06	6.76e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—STK11—pancreatic cancer	4.7e-06	6.75e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	4.7e-06	6.74e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	4.69e-06	6.74e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.68e-06	6.72e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—APOE—pancreatic cancer	4.67e-06	6.7e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—pancreatic cancer	4.6e-06	6.61e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	4.6e-06	6.6e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	4.55e-06	6.53e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	4.46e-06	6.41e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	4.46e-06	6.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CD44—pancreatic cancer	4.46e-06	6.4e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	4.46e-06	6.4e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.44e-06	6.38e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	4.44e-06	6.37e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.43e-06	6.37e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	4.42e-06	6.35e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—pancreatic cancer	4.42e-06	6.35e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—pancreatic cancer	4.42e-06	6.34e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	4.41e-06	6.34e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.41e-06	6.33e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—APOE—pancreatic cancer	4.41e-06	6.33e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—pancreatic cancer	4.39e-06	6.3e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFB1—pancreatic cancer	4.38e-06	6.28e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.36e-06	6.26e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—pancreatic cancer	4.35e-06	6.24e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	4.33e-06	6.22e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TYMS—pancreatic cancer	4.33e-06	6.21e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	4.33e-06	6.21e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.32e-06	6.21e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—pancreatic cancer	4.29e-06	6.16e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—pancreatic cancer	4.28e-06	6.14e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GCG—pancreatic cancer	4.27e-06	6.13e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—pancreatic cancer	4.25e-06	6.1e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—pancreatic cancer	4.22e-06	6.06e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	4.21e-06	6.04e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—pancreatic cancer	4.19e-06	6.01e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.17e-06	5.99e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	4.15e-06	5.96e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—pancreatic cancer	4.15e-06	5.96e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—pancreatic cancer	4.12e-06	5.91e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—pancreatic cancer	4.11e-06	5.91e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	4.09e-06	5.87e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.08e-06	5.86e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—pancreatic cancer	4.06e-06	5.83e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—pancreatic cancer	4.05e-06	5.82e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—pancreatic cancer	4.05e-06	5.82e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.04e-06	5.8e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—APOE—pancreatic cancer	4.04e-06	5.8e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—STK11—pancreatic cancer	4.02e-06	5.77e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	4.01e-06	5.75e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	4e-06	5.74e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	3.98e-06	5.71e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	3.97e-06	5.7e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	3.96e-06	5.68e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—pancreatic cancer	3.87e-06	5.55e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.86e-06	5.54e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—pancreatic cancer	3.85e-06	5.53e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	3.85e-06	5.52e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.84e-06	5.51e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—pancreatic cancer	3.83e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.83e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.77e-06	5.41e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—pancreatic cancer	3.72e-06	5.35e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.7e-06	5.31e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—pancreatic cancer	3.7e-06	5.31e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	3.7e-06	5.31e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—pancreatic cancer	3.69e-06	5.29e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	3.68e-06	5.28e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.65e-06	5.23e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—APOE—pancreatic cancer	3.61e-06	5.18e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	3.61e-06	5.18e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—pancreatic cancer	3.59e-06	5.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—pancreatic cancer	3.54e-06	5.08e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—pancreatic cancer	3.54e-06	5.08e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—pancreatic cancer	3.54e-06	5.07e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—APOE—pancreatic cancer	3.52e-06	5.05e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.52e-06	5.05e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	3.5e-06	5.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.46e-06	4.96e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—pancreatic cancer	3.45e-06	4.95e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—pancreatic cancer	3.44e-06	4.94e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CD44—pancreatic cancer	3.44e-06	4.94e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.41e-06	4.9e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	3.41e-06	4.9e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	3.41e-06	4.89e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—pancreatic cancer	3.39e-06	4.87e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—pancreatic cancer	3.34e-06	4.8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—pancreatic cancer	3.32e-06	4.77e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—APOE—pancreatic cancer	3.32e-06	4.76e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GCG—pancreatic cancer	3.3e-06	4.73e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—APOE—pancreatic cancer	3.29e-06	4.72e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—pancreatic cancer	3.26e-06	4.69e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.26e-06	4.67e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.23e-06	4.63e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.21e-06	4.6e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.2e-06	4.59e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.18e-06	4.56e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.14e-06	4.51e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	3.13e-06	4.49e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—pancreatic cancer	3.12e-06	4.48e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.11e-06	4.47e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—STK11—pancreatic cancer	3.1e-06	4.45e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—pancreatic cancer	3.08e-06	4.43e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—pancreatic cancer	3.07e-06	4.4e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.05e-06	4.38e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—pancreatic cancer	3.04e-06	4.37e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—pancreatic cancer	3.03e-06	4.35e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.02e-06	4.34e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	3.02e-06	4.33e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	3e-06	4.31e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.99e-06	4.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—pancreatic cancer	2.97e-06	4.27e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.97e-06	4.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—pancreatic cancer	2.97e-06	4.26e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—pancreatic cancer	2.95e-06	4.23e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—pancreatic cancer	2.9e-06	4.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	2.9e-06	4.16e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.89e-06	4.15e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.86e-06	4.11e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.86e-06	4.11e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—APOE—pancreatic cancer	2.81e-06	4.03e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.79e-06	4.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.79e-06	4.01e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.79e-06	4e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.77e-06	3.97e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—pancreatic cancer	2.76e-06	3.97e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	2.76e-06	3.96e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.72e-06	3.91e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	2.72e-06	3.9e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—pancreatic cancer	2.7e-06	3.88e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.67e-06	3.83e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.66e-06	3.82e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.63e-06	3.78e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.63e-06	3.78e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.61e-06	3.75e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	2.56e-06	3.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—pancreatic cancer	2.55e-06	3.66e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—pancreatic cancer	2.55e-06	3.66e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.54e-06	3.64e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	2.53e-06	3.63e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.49e-06	3.58e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.49e-06	3.58e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.47e-06	3.55e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—pancreatic cancer	2.46e-06	3.54e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.45e-06	3.51e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.43e-06	3.49e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.41e-06	3.47e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.41e-06	3.46e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	2.35e-06	3.37e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.29e-06	3.29e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.27e-06	3.26e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.27e-06	3.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—pancreatic cancer	2.27e-06	3.26e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.25e-06	3.23e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.23e-06	3.2e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.22e-06	3.19e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—pancreatic cancer	2.22e-06	3.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—pancreatic cancer	2.17e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—APOE—pancreatic cancer	2.17e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.16e-06	3.09e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—pancreatic cancer	2.1e-06	3.02e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—pancreatic cancer	2.07e-06	2.97e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.04e-06	2.92e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.98e-06	2.85e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.97e-06	2.82e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.97e-06	2.82e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.96e-06	2.81e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.94e-06	2.79e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.93e-06	2.76e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—pancreatic cancer	1.92e-06	2.75e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.89e-06	2.71e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.86e-06	2.67e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.72e-06	2.47e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.7e-06	2.45e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.68e-06	2.41e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.61e-06	2.31e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.52e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.52e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.5e-06	2.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.49e-06	2.13e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.48e-06	2.13e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.4e-06	2.01e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.39e-06	2e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.39e-06	1.99e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.3e-06	1.86e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.24e-06	1.78e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—pancreatic cancer	1.21e-06	1.74e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.18e-06	1.7e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.14e-06	1.64e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.13e-06	1.63e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—pancreatic cancer	9.68e-07	1.39e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	9.14e-07	1.31e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.47e-07	1.07e-05	CbGpPWpGaD
